N&O Index Card

Subject/Name: Glaxo Inc.

Article(s) Referenced In:

1. Glaxo expands (Photo) - Ja 10 89 1D
2. New ulcer drug could slow Glaxo's Zantac sales growth slightly - Ja 14 89 8B
3. Glaxo gives $80,000 to 37 arts agencies - Ja 28 89 2C
4. Burroughs Wellcome has direction; Glaxo still narrowing choices - Ja 29 89 3J
5. Idaho company agrees to head Glaxo project - Fe 10 89 5B
6. Offices on same floor - Fe 26 89 1I
7. Glaxo names president of Latin American operations - Mr 2 89 10B
8. Glaxo endows Wake artists program - Mr 23 89 10T
9. Helms in Tasmania as Glaxo seeks edge in 'opium war' - Mr 25 89 1C
10. Glaxo effort aimed at new drugs - Ap 26 89 5B
11. Editorial: Checking a gift horse - Ap 29 89 16A
12. Glaxo says progress made in developing new drugs - My 6 89 8B
13. Mario promoted at Glaxo Holdings - My 10 89 5B
14. Glaxo chief says new chairman will come from outside firm - My 24 89 6B
15. Glaxo chief (Mario) says new drugs will build the future of firm - My 28 89 1I
16. Glaxo reports $1.5 billion in sales, hiring increase - Jn 2 89 6B
17. Glaxo gives grant for AIDS education program - Jn 9 89 8B
18. Glaxo may form venture capital fund to aid in product development - Jn 14 89 5B
19. Glaxo might be interested in Robins plant - Jn 17 89 5B
20. Glaxo to announce plant construction - Jn 17 89 5B
21. Glaxo expected to name chief executive officer - Jn 21 89 6B
22. New Glaxo chief (Sanders) ready for business - Jn 22 89 6B
23. Glaxo planning first public image campaign - Jy 6 89 7B
24. (Zebulon) Recreation program gets grant - Jy 6 89 2T
25. Glaxo research executive (Cuatrecasas) to leave drug company - Jy 11 89 1D
26. Theater receives grant from Glaxo - Au 10 89 4T
27. Glaxo pledges $75,000 for Duke minorities - Au 16 89 10A
28. Glaxo Inc. - a chronology - Se 10 89 17A
29. In narrowing its focus, Glaxo loses its star scientist - Se 10 89 1
30. Glaxo a step ahead on moving research site - Se 17 89 1I
31. Sale of ulcer drug helps increase net income of Glaxo by about 20% - Se 20 89 5B
32. Glaxo seeks follow-up for profitable anti-ulcer drug - Oc 15 89 1I
33. Glaxo gives contribution to series - No 2 89 9T
34. Glaxo looks outside for new prescription drugs - No 3 89 8B
35. Glaxo presents first profit-sharing awards - No 17 89 7B
36. Glaxo plans incinerator for complex - No 18 89 2C
37. Glaxo begins program to help asthma victims - No 29 89 12A
38. Glaxo ends development of potentially risky ulcer drug - De 5 89 1D
39. Glaxo tests lab in a lab - De 10 89 1G
40. Glaxo signs agreement on cystic fibrosis drug - De 14 89 5C
41. No-nonsense boss at Glaxo is leery of top-heavy firms - De 24 89 1G

See a typo in our data? Let us know and we'll fix it.